9th Annual ADMET Conference

9th Annual ADMET Conference

30-06-2014 - 01-07-2014 London, United KingdomMarriott Hotel, Regents Park

The 9th annual ADMET Conference will focus on the role of ADMET in drug development. The event will look at the value of toxicity while addressing in silico and in vivo methods. The event will also focus on biologics versus small molecules in ADMET and an update on drug transporters.

The 9th annual ADMET Conference will focus on the role of ADMET in drug development. The event will look at the value of toxicity while addressing in silico and in vivo methods. The event will also focus on biologics versus small molecules in ADMET and an update on drug transporters.                 

Attendees will be at a distinct advantage and hear from the most important people in the field on themes including Predictive ADME, Screening Approaches, Pre-clinical Screening Approaches, and Predictive Toxicology, emerging issues such as, regulatory changes and Drug-Drug interactions.

Why Attend?

  • Understand how to integrate ADME and toxicity data to enhance the prediction and understanding of drug safety in humans
  • Hear the latest updates on drug transporters including the evolving transporter strategies in drug development and the different roles of drug transporters in R&D
  • Explore the ADME properties of peptides in drug discovery
  • Evaluate and overcome the challenges of making an accurate human dose prediction

Who should attend?

Chief Executives, Vice Presidents, Heads, Directors, Chief Scientists, Principle Scientists, and Project Leaders, Managers in:

  • ADME
  • Toxicology
  • DMPK
  • PD-PK
  • PBPK
  • Computational modelling and simulation
  • Computational chemistry
  • Computational toxicology
  • Pre-clinical safety
  • Clinical pharmacology
  • Gentoxicity
  • Drug metabolism
  • Regulatory Pharmaco-Toxicology

 

Company Spotlight

ImmunoGen

ImmunoGen

Ario Pharma

ario-pharma-small.jpg

Ario Pharma is a UK-based biopharmaceutical company that focuses on the development of drugs for the treatment of respiratory indications.

Back to top